Details for Patent: 8,198,483
✉ Email this page to a colleague
Title: | Phenethanolamine derivatives for treatment of respiratory diseases |
Abstract: | (1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-(2,2-dimethy- l-4H-1,3-benzodioxin-6-yl)ethanol and (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H-1,- 3-benzodioxin-6-yl)-1,3-oxazolidin-2-one are claimed. |
Inventor(s): | Box; Philip Charles (Stevenage, GB), Coe; Diane Mary (Stevenage, GB), Looker; Brian Edgar (Stevenage, GB), Mann; Inderjit Singh (Stevenage, GB), Procopiou; Panayiotis Alexandrou (Stevenage, GB) |
Assignee: | Glaxo Group Limited (Greenford, Middlesex, GB) |
Filing Date: | Jun 21, 2011 |
Application Number: | 13/165,037 |
Claims: | 1. A compound which is (1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-(2,2-dimethy- l-4H-1,3-benzodioxin-6-yl)ethanol. 2. (5R)-3-(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)-5-(2,2-dimethyl-4H- -1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one. |